<?xml version="1.0" encoding="UTF-8"?>
<ref id="B135-antioxidants-09-00636">
 <label>135.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Miao</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>De Clercq</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>G.</given-names>
   </name>
  </person-group>
  <article-title>Clinical significance of chemokine receptor antagonists</article-title>
  <source>Expert Opin. Drug Metab. Toxicol.</source>
  <year>2020</year>
  <volume>16</volume>
  <fpage>11</fpage>
  <lpage>30</lpage>
  <pub-id pub-id-type="doi">10.1080/17425255.2020.1711884</pub-id>
  <?supplied-pmid 31903790?>
  <pub-id pub-id-type="pmid">31903790</pub-id>
 </element-citation>
</ref>
